Global Meglumine Diatrizoate Injection Supply, Demand and Key Producers, 2023-2029

Global Meglumine Diatrizoate Injection Supply, Demand and Key Producers, 2023-2029

The global Meglumine Diatrizoate Injection market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

The major consumer markets for Meglumine Diatrizoate Injection are North America, Europe and the Asia-Pacific region. With the gradual recovery of the global economy after the COVID-19 outbreak and the return of major economies to normal, the medical industry will see certain growth. As the global medical level continues to improve, more and more hospitals and clinics are able to perform MRI and CT imaging. Therefore, the demand for Meglumine Diatrizoate Injection will increase in the foreseeable time.

Meglumine injection, indicated as this contrast agent for intravenous and retrograde urography; Cerebral, thoracic, abdominal and limbs angiography, venography and CT; It can also be used for arthrography, fistula imaging, hysterosalpingography, endoscopic retrograde cholangiopancreatography (ERCP), sialography, and other tests. Meglumine injection should not be used in selective coronary angiography. It should not be used for myelography, ventriculography, or cisternography as it may induce neurotoxic symptoms.

This report studies the global Meglumine Diatrizoate Injection production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Meglumine Diatrizoate Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Meglumine Diatrizoate Injection that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Meglumine Diatrizoate Injection total production and demand, 2018-2029, (K Bottles)

Global Meglumine Diatrizoate Injection total production value, 2018-2029, (USD Million)

Global Meglumine Diatrizoate Injection production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Bottles)

Global Meglumine Diatrizoate Injection consumption by region & country, CAGR, 2018-2029 & (K Bottles)

U.S. VS China: Meglumine Diatrizoate Injection domestic production, consumption, key domestic manufacturers and share

Global Meglumine Diatrizoate Injection production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Bottles)

Global Meglumine Diatrizoate Injection production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Bottles)

Global Meglumine Diatrizoate Injection production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Bottles)

This reports profiles key players in the global Meglumine Diatrizoate Injection market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include AdvaCare Pharma, Shanghai Xudong Haipu Pharmaceutical, Hunan Hansen Pharmaceutical, Shanghai Bracco Sine Pharmaceutical, Lunan Pharmaceutical and Xi'an Hanfeng Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Meglumine Diatrizoate Injection market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Bottles) and average price (US$/Bottle) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Meglumine Diatrizoate Injection Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Meglumine Diatrizoate Injection Market, Segmentation by Type
1ml/0.3g
20ml/15.2g
20ml/12g
100ml/60g

Global Meglumine Diatrizoate Injection Market, Segmentation by Application
Hospital
Clinic
Pharmacy

Companies Profiled:
AdvaCare Pharma
Shanghai Xudong Haipu Pharmaceutical
Hunan Hansen Pharmaceutical
Shanghai Bracco Sine Pharmaceutical
Lunan Pharmaceutical
Xi'an Hanfeng Pharmaceutical

Key Questions Answered

1. How big is the global Meglumine Diatrizoate Injection market?

2. What is the demand of the global Meglumine Diatrizoate Injection market?

3. What is the year over year growth of the global Meglumine Diatrizoate Injection market?

4. What is the production and production value of the global Meglumine Diatrizoate Injection market?

5. Who are the key producers in the global Meglumine Diatrizoate Injection market?

6. What are the growth factors driving the market demand?